DR. MILTON BROWN

Trocar Pharma and its scientists have created a tissue-targeted, platform technology focused on allowing humans to survive in the harsh environment of outer space while simultaneously utilizing these same technologies to increase human longevity on Earth. Trocar’s platform technology uniquely targets intercellular reactive oxygen species (ROS) with in vivo studies confirming the efficacy of our therapeutics in regenerating stem cells and increasing life span. With over 50% of all deaths attributable to inflammation-related diseases and the overproduction of ROS leading to oxidative stress and chronic inflammation, our platform technology has a myriad of use cases. Trocar’s three-prong therapeutic strategy is focused on: 1. Radiation mitigation & protection (on Earth & outside LEO) 2. Oncology 3. Chronic and degenerative diseases